Business Description
Silence Therapeutics is a London-based biotechnology company founded in 1994 that uses a gene-silencing technology called siRNA to develop treatments for blood disorders, heart disease, kidney conditions, and obesity. Its pipeline includes several drugs at various stages of clinical development, targeting conditions such as high lipoprotein(a) levels, high cholesterol, and rare diseases affecting the kidneys and blood.
